跳至主要内容
临床试验/CTRI/2010/091/001321
CTRI/2010/091/001321已完成4 期

The study of effects of Probiotic lactobacilli in Preventing Major Complications in patients of Liver Cirrhosis.

nique Biotech, Chennai, India0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age: 30 to 50 years
  • Patient with sonographically confirmed diagnosis of cirrhosis
  • Patients with liver cirrhosis with the history of major complication of cirrhosis (including variceal bleeding, encephalopathy and spontaneous bacterial peritonitis)
  • Evidence for portal hypertension

排除标准

  • Patients with alcoholic cirrhosis who still consume alcohol
  • Patients having risk factor of small intestinal bacterial overgrowth other than cirrhosis - diabetes mellitus, history of abdominal surgery, immunomodulator drugs
  • Patients with active or recent G.I. bleeding (within prior 7 days)
  • Patients with advanced hepatocellular carcinoma, renal failure and portal vein thrombosis

研究者

发起方
nique Biotech, Chennai, India

相似试验